Cellectar Biosciences, Inc. — Director's Dealing 2018

Apr 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2018-04-06

Reporting Person: POSNER BRIAN M (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-06	Stock option (right to buy)	$1.17	A	80000	Acquired	2028-04-06	Common Stock (80000)	Direct

Footnotes

F1: Options vest in equal annual increments over a period of three years from the date of grant.